Skip to main content

Table 3 Effective dose estimates

From: Human biodistribution and internal dosimetry of 4-[ 18F]fluorobenzyl-dexetimide: a PET radiopharmaceutical for imaging muscarinic acetylcholine receptors in the brain and heart

 

Effective dose (μSv/MBq)

 

Sample mean

Sample 95% CI

Range

Male

17.82

0.96

17.13, 18.51

Female

20.96

2.97

18.91, 24.66

All subjects

19.70

2.27

17.13, 24.66

  1. Female subject effective doses: 19.30, 18.91, 24.66 μSv/MBq
  2. Male subject effective doses: 17.13, 18.51 μSv/MBq
  3. Effective doses calculated using ICRP 103 tissue weighting factors and each individual subjects biokinetic uptake data